Peter’s blogs written in English
‘Good morning Mr. Smith. Good to see you, how are you doing? You’re looking for a new car? That’s good news. We decided that it’s going to be a Ford Focus, ST, 2.0 Eco-boost, 184 KW, 6-gear. Let’s see in stock if there is a possibility that you decide on Lees meer…
Chinese Clinical Oncology 2016 I want my Olaparib and I want it now! ‘Because I have cancer above the midriff, I can go and whistle for that drug, but it would have been given to me if the cancer had been under the midriff’. It’s an emotional outburst from Lees meer…
Annals of Translational Medicine, 2016;4(1):22 Trials are not for the benefit of patients. They are set up to enable the pharmaceutical industry to register new drugs. And the only thing the industry needs is a drug that performs better than the one it is meant to replace, or a placebo. Lees meer…
Approximately 200 billion euros is spent on cancer research worldwide each year. This statistic could no doubt be slightly qualified; it may be higher, it may be lower. However, the point is that it’s a lot of money and the results are less than wonderful – at least, if you Lees meer…
This article was first published in Chinese Clinical Oncology, CCO-2014-CWDD-01 Summary. The result of drug development so far is beyond expectations and also beyond what’s possible. The reason for this is probably that the aim is not a better quality of life for the patient and her loved ones but Lees meer…
Healthcare is there because of us, the patients. Because there are patients, people have jobs, profits are made and losses incurred, and the healthcare sector can thrive. Ask anyone, and they’ll tell you the same. And then I reply: that’s all very nice, but do you really feel that’s true? Lees meer…
‘Give people rules and they stop thinking for themselves’. I actually believe this to be true. We’re always talking about our own responsibility and free will and do not realise that rules do nothing else than impose limits on our own responsibility and free will. Or worse than that; we Lees meer…
The other day I attended a gathering of the European Organisation for the Research and Treatment of Cancer (EORTC), where I talked to some 75 doctors, scientists, pharmaceuticals staff, government officials and also, luckily, naturally, patients, about the set-up of new types of trials. And I thought, “What can I Lees meer…
Last week I met with two passionate research physicians working on esophageal, stomach and pancreatic cancer. Patients suffering from these forms of cancer nearly all die, because hardly any research is being done. We don´t know anything about these patients. Many of them are treated palliatively only. As a basis Lees meer…
‘The tissue is not the issue’ I once heard an American scientist say a couple of years ago. What he meant was, rather than focusing solely on the tissue or organ the cancer is affecting, it is more important to stop the division of cells that is causing its spread: Lees meer…